Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.

Brown KW, Charles A, Dallosso A, White G, Charlet J, Standen GR, Malik K.

Cancer Genet. 2012 Jun;205(6):319-26. doi: 10.1016/j.cancergen.2012.04.009.

PMID:
22749038
[PubMed - indexed for MEDLINE]
2.

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L, Green DM, Beckwith JB, Perlman EJ.

Neoplasia. 2012 Aug;14(8):742-56.

PMID:
22952427
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Haruta M, Arai Y, Watanabe N, Fujiwara Y, Honda S, Ohshima J, Kasai F, Nakadate H, Horie H, Okita H, Hata J, Fukuzawa M, Kaneko Y.

Cancer Sci. 2012 Jun;103(6):1129-35. doi: 10.1111/j.1349-7006.2012.02269.x. Epub 2012 Apr 19.

PMID:
22409817
[PubMed - indexed for MEDLINE]
4.

WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.

Cardoso LC, De Souza KR, De O Reis AH, Andrade RC, Britto AC Jr, De Lima MA, Dos Santos AC, De Faria PS, Ferman S, Seuánez HN, Vargas FR.

Oncol Rep. 2013 Jan;29(1):315-20. doi: 10.3892/or.2012.2096. Epub 2012 Oct 19.

PMID:
23117548
[PubMed - indexed for MEDLINE]
5.

Stratification of Wilms tumor by genetic and epigenetic analysis.

Scott RH, Murray A, Baskcomb L, Turnbull C, Loveday C, Al-Saadi R, Williams R, Breatnach F, Gerrard M, Hale J, Kohler J, Lapunzina P, Levitt GA, Picton S, Pizer B, Ronghe MD, Traunecker H, Williams D, Kelsey A, Vujanic GM, Sebire NJ, Grundy P, Stiller CA, Pritchard-Jones K, Douglas J, Rahman N.

Oncotarget. 2012 Mar;3(3):327-35.

PMID:
22470196
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pathology, genetics and cytogenetics of Wilms' tumour.

Md Zin R, Murch A, Charles A.

Pathology. 2011 Jun;43(4):302-12. doi: 10.1097/PAT.0b013e3283463575. Review.

PMID:
21516053
[PubMed - indexed for MEDLINE]
7.

Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.

Wang H, Shen Y, Sun N, Jiang YP, Li ML, Sun L.

Chin Med J (Engl). 2012 May;125(10):1733-9.

PMID:
22800892
[PubMed - indexed for MEDLINE]
Free Article
8.

Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.

Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B.

Mol Cancer Res. 2005 Sep;3(9):493-502.

PMID:
16179496
[PubMed - indexed for MEDLINE]
Free Article
9.

Canonical WNT signalling determines lineage specificity in Wilms tumour.

Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE.

Oncogene. 2009 Feb 26;28(8):1063-75. doi: 10.1038/onc.2008.455. Epub 2009 Jan 12.

PMID:
19137020
[PubMed - indexed for MEDLINE]
10.

WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.

Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M.

Genes Chromosomes Cancer. 2009 Dec;48(12):1102-11. doi: 10.1002/gcc.20712.

PMID:
19760609
[PubMed - indexed for MEDLINE]
11.

Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.

Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ.

Semin Diagn Pathol. 1994 May;11(2):126-35. Review.

PMID:
7809506
[PubMed - indexed for MEDLINE]
12.

Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.

Murphy AJ, Axt JR, de Caestecker C, Pierce J, Correa H, Seeley EH, Caprioli RM, Newton MW, de Caestecker MP, Lovvorn HN 3rd.

Int J Cancer. 2012 Sep 15;131(6):E983-94. doi: 10.1002/ijc.27544. Epub 2012 Apr 4.

PMID:
22437966
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.

Ruteshouser EC, Robinson SM, Huff V.

Genes Chromosomes Cancer. 2008 Jun;47(6):461-70. doi: 10.1002/gcc.20553.

PMID:
18311776
[PubMed - indexed for MEDLINE]
14.

Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.

Dallosso AR, Hancock AL, Szemes M, Moorwood K, Chilukamarri L, Tsai HH, Sarkar A, Barasch J, Vuononvirta R, Jones C, Pritchard-Jones K, Royer-Pokora B, Lee SB, Owen C, Malik S, Feng Y, Frank M, Ward A, Brown KW, Malik K.

PLoS Genet. 2009 Nov;5(11):e1000745. doi: 10.1371/journal.pgen.1000745. Epub 2009 Nov 26. Erratum in: PLoS Genet. 2009 Dec;5(12). doi: 10.1371/annotation/012d5a44-8239-4057-8c3b-3dc159ea3a02.

PMID:
19956686
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor.

Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G, Negrini M.

Cancer Res. 2000 Mar 15;60(6):1521-5.

PMID:
10749116
[PubMed - indexed for MEDLINE]
Free Article
16.

Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.

Brown KW, Power F, Moore B, Charles AK, Malik KT.

Mol Cancer Res. 2008 Jul;6(7):1114-23. doi: 10.1158/1541-7786.MCR-08-0002.

PMID:
18644976
[PubMed - indexed for MEDLINE]
Free Article
17.

Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

Royer-Pokora B, Busch M, Beier M, Duhme C, de Torres C, Mora J, Brandt A, Royer HD.

Hum Mol Genet. 2010 May 1;19(9):1651-68. doi: 10.1093/hmg/ddq042. Epub 2010 Jan 27.

PMID:
20106868
[PubMed - indexed for MEDLINE]
Free Article
18.

Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.

Satoh Y, Nakadate H, Nakagawachi T, Higashimoto K, Joh K, Masaki Z, Uozumi J, Kaneko Y, Mukai T, Soejima H.

Br J Cancer. 2006 Aug 21;95(4):541-7. Epub 2006 Aug 8.

PMID:
16909133
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.

Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE.

J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366.

PMID:
18484682
[PubMed - indexed for MEDLINE]
20.

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.

Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER.

Br J Cancer. 2005 Apr 25;92(8):1574-80.

PMID:
15798773
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk